ISC 2021

Improving Patient Outcomes, Balancing Cost of Mobile Stroke Units with Louise McCullough, MD, PhD

March 23, 2021

Check out this interview with Louise McCullough, MD, PhD, Program Chair of ISC 21, where she offers perspective on mobile stroke units and what barriers prevent further implementation of the specialized ambulatory units.

Understanding the American Heart Association's Scientific Statement on Brain Health

March 20, 2021

Just ahead of the International Stroke Conference, the AHA released a scientific statement focusing on brain health and aimed at providing primary care providers an overview of factors influencing neurologic health.

AHA Registry Provides Comprehensive Review of Ischemic Stroke in COVID-19 Patients

March 19, 2021

Using data from the AHA's COVID-19 Cardiovascular Disease Registry, a new analysis presented at ISC 21 provides an overview of the overall risk, risk factors, and outcomes of COVID-19-related ischemic stroke among US patients.

Mobile Stroke Units Proving Their Worth But Limited by Reimbursement Issues

March 18, 2021

A pair of studies from ISC 21 is providing insight into the benefits of mobile stroke units while also highlighting current barriers to widespread implementation of these units.

Immediate Angiography Could Preserve Function, Improve Outcomes in LVO Stroke

March 17, 2021

An interim analysis of the ANGIOCAT trial suggests immediate angiography could help preserve function and improve outcomes in the treatment of patients with stroke caused by a large vessel occlusion compared to the current standard of performing a CT scan.

Black Medicare Patients 4% More Likely to Die in Decade Following Stroke than White Counterparts

March 17, 2021

A study from ISC 21 suggests Black patients using Medicare were 4% more likely to die in the first 10 years after a stroke than their white counterparts.

Adding Icosapent Ethyl to Statin Therapy Reduces Stroke Risk by 36%, Study Finds

March 16, 2021

An analysis of the REDUCE-IT trial suggests patients on statins who were also receiving icosapent ethyl reduced their risk of an ischemic stroke by an additional 36%.